From January 1, 2024 to January 11, 2024, the company has repurchased 1,049,800 shares, representing 0.22% for CNY 60 million. With this, the company has completed the repurchase of 1,696,800 shares, representing 0.36% for CNY 99.99 million under the buyback announced on December 19, 2023.
Guangzhou Kingmed Diagnostics Group Co., Ltd.
Equities
603882
CNE100002VW1
Healthcare Facilities & Services
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
38.65 CNY | +6.06% | +8.38% | -38.23% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.23% | 2.35B | |
-25.81% | 8.55B | |
+68.22% | 4.24B | |
-1.63% | 2.53B | |
-9.63% | 2.44B | |
-7.85% | 1.89B | |
-17.74% | 1.55B | |
-39.48% | 1.23B | |
+9.68% | 1.13B | |
+19.57% | 994M |
- Stock Market
- Equities
- 603882 Stock
- News Guangzhou Kingmed Diagnostics Group Co., Ltd.
- Tranche Update on Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback Plan announced on December 19, 2023.